5F-ADBICA
5F-ADBICA is a designer drug that belongs to the cannabinoid class. It is an analogue of ADBICA, a cannabinoid receptor agonist. 5F-ADBICA was first identified in Japan in 2013. It is illegal in some countries due to its psychoactive properties.
Chemistry[edit | edit source]
5F-ADBICA is a synthetic cannabinoid that is structurally related to ADBICA. It has a molecular formula of C20H28FN3O3 and a molecular weight of 377.46 g/mol. The compound is characterized by a fluoropentyl chain attached to the indole core of ADBICA.
Pharmacology[edit | edit source]
As a synthetic cannabinoid, 5F-ADBICA acts as an agonist at the cannabinoid receptors, mimicking the effects of cannabis. However, the exact mechanism of action and the full spectrum of its effects are not fully understood.
Legal Status[edit | edit source]
5F-ADBICA is classified as a Schedule I controlled substance in the United States. It is also illegal in several other countries, including Japan and Sweden.
Health Risks[edit | edit source]
The use of 5F-ADBICA can lead to a range of adverse health effects, including psychosis, seizures, and cardiac arrest. Due to its potency and the lack of research on its effects, it is considered a high-risk substance.
See Also[edit | edit source]
5F-ADBICA Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD